Trials / Completed
CompletedNCT00323479
Arthralgia During Anastrozole Therapy for Breast Cancer
A Multicentre, Open Study Assessing Joint Disorders Under ARIMIDEX® (1mg/Day) as Adjuvant Treatment in Post Menopausal Women With Early Breast Cancer
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the joint symptoms and structural joint changes under anastrozole as adjuvant treatment in postmenopausal women with early breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anastrozole | 1mg/Day oral |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2006-05-09
- Last updated
- 2012-04-06
- Results posted
- 2012-04-06
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00323479. Inclusion in this directory is not an endorsement.